Alpha Teknova, Inc. (NASDAQ:TKNO – Get Free Report) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 1,660,000 shares, an increase of 72.2% from the February 13th total of 964,000 shares. Based on an average daily volume of 319,200 shares, the short-interest ratio is presently 5.2 days. Approximately 15.7% of the company’s shares are sold short.
Alpha Teknova Stock Performance
Shares of TKNO stock traded up $0.38 during trading on Friday, hitting $5.58. The company’s stock had a trading volume of 146,708 shares, compared to its average volume of 304,013. The business has a fifty day moving average of $7.79 and a 200-day moving average of $6.91. Alpha Teknova has a 52 week low of $1.16 and a 52 week high of $10.37. The company has a market cap of $298.18 million, a PE ratio of -7.54 and a beta of 0.41. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12.
Alpha Teknova (NASDAQ:TKNO – Get Free Report) last issued its quarterly earnings data on Tuesday, March 4th. The company reported ($0.11) earnings per share (EPS) for the quarter. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The business had revenue of $9.27 million during the quarter, compared to analysts’ expectations of $9.10 million. As a group, research analysts anticipate that Alpha Teknova will post -0.58 earnings per share for the current year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Separately, Craig Hallum initiated coverage on Alpha Teknova in a research note on Monday, February 10th. They issued a “buy” rating and a $12.00 price objective for the company.
Check Out Our Latest Stock Report on TKNO
Alpha Teknova Company Profile
Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
See Also
- Five stocks we like better than Alpha Teknova
- What is Insider Trading? What You Can Learn from Insider Trading
- How to Build the Ultimate Everything ETF Portfolio
- What Does a Stock Split Mean?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What does consumer price index measure?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.